Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07262190 · ClinicalTrials.gov registry record · NA
NavSTAR Implementation Effectiveness Trial Across a Health System
A NA study of Opioid Use Disorder, sponsored by Friends Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 720
- Enrollment target
- 1
- Study location
NCT07262190 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Friends Research Institute. The registered enrollment target is 720 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07262190, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Friends Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 720 participants
- Enrollment target
- 1
- Study location
Study Summary
Patient Navigation (PN) interventions following hospitalization can improve outcomes for people with opioid use disorder treatment. Delivering PN interventions on a wide scale requires many resources and coordination across institutions. This will use an evidence-based process to find solutions to these significant barriers by engaging community, hospital, and patient partners. This study is being conducted to learn more about how to implement NavSTAR, a patient navigation intervention for people with opioid use disorder, across a health system. The research team showed in a previous study with 400 participants that NavSTAR significantly increased entry into opioid use disorder treatment, reduced readmissions to the hospital, and was highly cost- effective compared to treatment as usual. This study will first pilot NavSTAR with 32 patient participants across 4 hospitals in the City of Philadelphia. Then, a large trial with 720 patient participants will be conducted to see if people who need the intervention are reached, and a sustainable plan will be created to continue the intervention after the grant award period.
Conditions Studied
Interventions
- BEHAVIORAL NavSTAR (Philly adaptation)
Study Locations (1)
Pennsylvania
- Jefferson Health - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07262190
The ClinicalTrials.gov registry entry for NCT07262190 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (85% lower). The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which NavSTAR (Philly adaptation) is the first listed.
NCT07262190 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07262190 about?
NCT07262190 is a clinical study titled "NavSTAR Implementation Effectiveness Trial Across a Health System". Patient Navigation (PN) interventions following hospitalization can improve outcomes for people with opioid use disorder treatment. Delivering PN interventions on a wide scale requires many resources and coordination across institutions. This will use an evidence-based process to find solutions to t...
What is the current status of trial NCT07262190?
This trial is currently recruiting. It is a NA study. The enrollment target is 720 participants. The study started on 2025-10-27. Estimated completion is 2029-08-01.
What conditions does trial NCT07262190 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT07262190?
The interventions under investigation include: NavSTAR (Philly adaptation) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07262190?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07262190 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.